Clinical Trial Update: Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a combination of lenvatinib, adebrelimab, and GEMOX as perioperative treatment for potentially resectable intrahepatic cholangiocarcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Zhiyong Huang | Conditions: Intrahepatic Cholangiocarcinoma | Phase 4 | Status: NOT_YET_RECRUITING